Illumina Inc (NASDAQ:ILMN)

During the Trading Day
220.51 +0.44 / +0.20%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
220.51 0.00 / 0.00%
Volume: 1.2K
Health Technology

Company Description

Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and function. The company provides sequencing and array-based solutions for genetic analysis in addition to selling products, it provide genotyping, NIPT and whole-genome sequencing services. Its customers include leading genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Contact Information

Illumina, Inc.
5200 Illumina Way
San Diego California 92122
P:(858) 202-4500
Investor Relations:
(858) 255-5243



Individual stakeholders6.61%
Mutual fund holders49.70%
Other institutional46.09%

Top Executives

Jay T. FlatleyChief Executive Officer & Director
Francis A. deSouzaPresident & Director
Robert P. RagusaSenior Vice President-Global Quality & Operations
Marc A. StapleyChief Financial Officer & Senior Vice President
Mostafa RonaghiChief Technology Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account